FindTrial
Sign In

Posterior chamber implantation of iris-claw intraocular lens (IOL) for the treatment of Marfan syndrome with lens dislocation in children

Posterior chamber implantation of iris-claw intraocular lens (IOL) for the treatment of Marfan syndrome with lens dislocation in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONh-17011320
Enrollment
Unknown
Registered
2017-05-07
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Marfan syndrome with lens dislocation in children

Interventions

Treating Group:Phacoemulsification & Posterior chamber implantation of iris-claw intraocular lens

Sponsors

Aier Eye Hospital Group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 2000 ? / mm2; 4. preoperative best corrected visual acuity (BCVA) 180 degree; 7. Skeletal changes, tubular bone elongated; 8. With family history.

Exclusion criteria

Exclusion criteria: 1. Systemic diseases with surgical contraindications; 2. People who cannot tolerate to general anesthesia.

Design outcomes

Primary

MeasureTime frame
uncorrected visual acuity;best corrected visual acuitv;Diopter;endothelial cell counts;Pupil morphology;Iris morphology;IOL position;—

Secondary

MeasureTime frame
Intraocular pressure;Anterior chamber depth;—

Countries

China

Contacts

Public ContactYong Wang

Aier Eye Hospital Group

wangyongeye@163.com+86 13971519950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026